Loading…

Improvement of Blood Pressure Control in a Hypertension Clinic in Japan: A 15-Year Follow-Up Study

Many guidelines recommended strict blood pressure (BP) control to prevent cardiovascular events. However, BP control in a substantial majority of hypertensives remains to be insufficient. We have determined the trends of BP control of the same patients during 15 years in a hypertension clinic. One h...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental hypertension (1993) 2009-11, Vol.31 (7), p.553-559
Main Authors: Ohta, Yuko, Matsumura, Kiyoshi, Tsuchihashi, Takuya, Ohtsubo, Toshio, Arima, Hisatomi, Miwa, Yoshikazu, Goto, Kenichi, Ohya, Yusuke, Fujii, Koji, Uezono, Keiko, Abe, Isao, Iida, Mitsuo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c471t-1c6a2d9897c0824213b259ff61b8d03086ba33fa00fff9409bd710647d5d0a3f3
cites cdi_FETCH-LOGICAL-c471t-1c6a2d9897c0824213b259ff61b8d03086ba33fa00fff9409bd710647d5d0a3f3
container_end_page 559
container_issue 7
container_start_page 553
container_title Clinical and experimental hypertension (1993)
container_volume 31
creator Ohta, Yuko
Matsumura, Kiyoshi
Tsuchihashi, Takuya
Ohtsubo, Toshio
Arima, Hisatomi
Miwa, Yoshikazu
Goto, Kenichi
Ohya, Yusuke
Fujii, Koji
Uezono, Keiko
Abe, Isao
Iida, Mitsuo
description Many guidelines recommended strict blood pressure (BP) control to prevent cardiovascular events. However, BP control in a substantial majority of hypertensives remains to be insufficient. We have determined the trends of BP control of the same patients during 15 years in a hypertension clinic. One hundred three patients (age 32-91, mean 68 ± 11 years in 2006), who were followed at our hypertension clinic between 1991-2006, were retrospectively investigated. We compared the clinical characteristics of the patients in 2006 to those in 1991, 1996, and 2001, using the averaged BP determined at two occasions of each year for our analysis. The average BP decreased from 144 ± 17 87 ± 10 mmHg to 132 ± 12 75 ± 10 mmHg (p < 0.01) during the 15 years between 1991 and 2006. When good BP control was defined as < 140 90 mmHg, the rate of patients with good BP control increased from 35% in 1991 to 45% in 1996, to 54% in 2001 (p < 0.01 vs. 1991), and to 72% in 2006 (p < 0.01 vs. 1991). The number of anti-hypertensive drugs used in 2006 significantly increased compared to those in 1991, 1996, and 2001. More specifically, the use of diuretics and α-blockers increased significantly during this period. Results suggest that BP control improved in the 15 years studied, and the increased use of the anti-hypertensive drugs, as well as the increased awareness of the importance of strict BP control, seems to have contributed to improve the BP control.
doi_str_mv 10.3109/10641960902927960
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734122243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734122243</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-1c6a2d9897c0824213b259ff61b8d03086ba33fa00fff9409bd710647d5d0a3f3</originalsourceid><addsrcrecordid>eNp9kE9P3DAQxS3Uin_lA3BBvvWUMrYTJ4ZellUXFiGB1HLoKXJiW2Tl2KmdgPbb49WuhBCipxlpfu9p3kPolMAPRkCcE-A5ERwEUEHLtOyhQ1LQIuMA_Eva0z1LADtARzGuAEjOi2ofHRBRVbwq2CFqlv0Q_LPutRuxN_jKeq_wQ9AxTkHjuXdj8BZ3Dkt8sx50GLWLnXd4bjvXtZvDrRyku8AzTIrsr5YBL7y1_iV7HPDvcVLrb-irkTbqk908Ro-LX3_mN9nd_fVyPrvL2rwkY0ZaLqkSlShbqGhOCWtoIYzhpKkUMKh4IxkzEsAYI3IQjSo3AUtVKJDMsGP0feubAv2bdBzrvouttlY67adYlywnlNKcJZJsyTb4GIM29RC6XoZ1TaDeNFt_aDZpznbuU9Nr9abYVZmAn1ugc8aHXr74YFU9yrX1wQTp2i5uvD_3v3wnf9LSjk-tDLpe-Sm41Nx_vnsF9NKXSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734122243</pqid></control><display><type>article</type><title>Improvement of Blood Pressure Control in a Hypertension Clinic in Japan: A 15-Year Follow-Up Study</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Ohta, Yuko ; Matsumura, Kiyoshi ; Tsuchihashi, Takuya ; Ohtsubo, Toshio ; Arima, Hisatomi ; Miwa, Yoshikazu ; Goto, Kenichi ; Ohya, Yusuke ; Fujii, Koji ; Uezono, Keiko ; Abe, Isao ; Iida, Mitsuo</creator><creatorcontrib>Ohta, Yuko ; Matsumura, Kiyoshi ; Tsuchihashi, Takuya ; Ohtsubo, Toshio ; Arima, Hisatomi ; Miwa, Yoshikazu ; Goto, Kenichi ; Ohya, Yusuke ; Fujii, Koji ; Uezono, Keiko ; Abe, Isao ; Iida, Mitsuo</creatorcontrib><description>Many guidelines recommended strict blood pressure (BP) control to prevent cardiovascular events. However, BP control in a substantial majority of hypertensives remains to be insufficient. We have determined the trends of BP control of the same patients during 15 years in a hypertension clinic. One hundred three patients (age 32-91, mean 68 ± 11 years in 2006), who were followed at our hypertension clinic between 1991-2006, were retrospectively investigated. We compared the clinical characteristics of the patients in 2006 to those in 1991, 1996, and 2001, using the averaged BP determined at two occasions of each year for our analysis. The average BP decreased from 144 ± 17 87 ± 10 mmHg to 132 ± 12 75 ± 10 mmHg (p &lt; 0.01) during the 15 years between 1991 and 2006. When good BP control was defined as &lt; 140 90 mmHg, the rate of patients with good BP control increased from 35% in 1991 to 45% in 1996, to 54% in 2001 (p &lt; 0.01 vs. 1991), and to 72% in 2006 (p &lt; 0.01 vs. 1991). The number of anti-hypertensive drugs used in 2006 significantly increased compared to those in 1991, 1996, and 2001. More specifically, the use of diuretics and α-blockers increased significantly during this period. Results suggest that BP control improved in the 15 years studied, and the increased use of the anti-hypertensive drugs, as well as the increased awareness of the importance of strict BP control, seems to have contributed to improve the BP control.</description><identifier>ISSN: 1064-1963</identifier><identifier>EISSN: 1525-6006</identifier><identifier>DOI: 10.3109/10641960902927960</identifier><identifier>PMID: 19886853</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adrenergic alpha-Antagonists - therapeutic use ; Adrenergic beta-Antagonists - therapeutic use ; Aged ; Angiotensin II Type 1 Receptor Blockers - therapeutic use ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; anti-hypertensive drugs ; Antihypertensive Agents - therapeutic use ; Blood Pressure - drug effects ; BP control ; diuretics ; Diuretics - therapeutic use ; follow-up patients ; Follow-Up Studies ; Humans ; Hypertension - blood ; Hypertension - drug therapy ; Hypertension - physiopathology ; Japan ; Male ; Middle Aged ; Outpatient Clinics, Hospital ; Practice Guidelines as Topic ; Renin-Angiotensin System - drug effects ; Retrospective Studies ; Time Factors ; Treatment Outcome ; α-blockers</subject><ispartof>Clinical and experimental hypertension (1993), 2009-11, Vol.31 (7), p.553-559</ispartof><rights>Informa UK, Ltd. 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-1c6a2d9897c0824213b259ff61b8d03086ba33fa00fff9409bd710647d5d0a3f3</citedby><cites>FETCH-LOGICAL-c471t-1c6a2d9897c0824213b259ff61b8d03086ba33fa00fff9409bd710647d5d0a3f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19886853$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohta, Yuko</creatorcontrib><creatorcontrib>Matsumura, Kiyoshi</creatorcontrib><creatorcontrib>Tsuchihashi, Takuya</creatorcontrib><creatorcontrib>Ohtsubo, Toshio</creatorcontrib><creatorcontrib>Arima, Hisatomi</creatorcontrib><creatorcontrib>Miwa, Yoshikazu</creatorcontrib><creatorcontrib>Goto, Kenichi</creatorcontrib><creatorcontrib>Ohya, Yusuke</creatorcontrib><creatorcontrib>Fujii, Koji</creatorcontrib><creatorcontrib>Uezono, Keiko</creatorcontrib><creatorcontrib>Abe, Isao</creatorcontrib><creatorcontrib>Iida, Mitsuo</creatorcontrib><title>Improvement of Blood Pressure Control in a Hypertension Clinic in Japan: A 15-Year Follow-Up Study</title><title>Clinical and experimental hypertension (1993)</title><addtitle>Clin Exp Hypertens</addtitle><description>Many guidelines recommended strict blood pressure (BP) control to prevent cardiovascular events. However, BP control in a substantial majority of hypertensives remains to be insufficient. We have determined the trends of BP control of the same patients during 15 years in a hypertension clinic. One hundred three patients (age 32-91, mean 68 ± 11 years in 2006), who were followed at our hypertension clinic between 1991-2006, were retrospectively investigated. We compared the clinical characteristics of the patients in 2006 to those in 1991, 1996, and 2001, using the averaged BP determined at two occasions of each year for our analysis. The average BP decreased from 144 ± 17 87 ± 10 mmHg to 132 ± 12 75 ± 10 mmHg (p &lt; 0.01) during the 15 years between 1991 and 2006. When good BP control was defined as &lt; 140 90 mmHg, the rate of patients with good BP control increased from 35% in 1991 to 45% in 1996, to 54% in 2001 (p &lt; 0.01 vs. 1991), and to 72% in 2006 (p &lt; 0.01 vs. 1991). The number of anti-hypertensive drugs used in 2006 significantly increased compared to those in 1991, 1996, and 2001. More specifically, the use of diuretics and α-blockers increased significantly during this period. Results suggest that BP control improved in the 15 years studied, and the increased use of the anti-hypertensive drugs, as well as the increased awareness of the importance of strict BP control, seems to have contributed to improve the BP control.</description><subject>Adrenergic alpha-Antagonists - therapeutic use</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Aged</subject><subject>Angiotensin II Type 1 Receptor Blockers - therapeutic use</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>anti-hypertensive drugs</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Blood Pressure - drug effects</subject><subject>BP control</subject><subject>diuretics</subject><subject>Diuretics - therapeutic use</subject><subject>follow-up patients</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hypertension - blood</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Japan</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Outpatient Clinics, Hospital</subject><subject>Practice Guidelines as Topic</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>α-blockers</subject><issn>1064-1963</issn><issn>1525-6006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kE9P3DAQxS3Uin_lA3BBvvWUMrYTJ4ZellUXFiGB1HLoKXJiW2Tl2KmdgPbb49WuhBCipxlpfu9p3kPolMAPRkCcE-A5ERwEUEHLtOyhQ1LQIuMA_Eva0z1LADtARzGuAEjOi2ofHRBRVbwq2CFqlv0Q_LPutRuxN_jKeq_wQ9AxTkHjuXdj8BZ3Dkt8sx50GLWLnXd4bjvXtZvDrRyku8AzTIrsr5YBL7y1_iV7HPDvcVLrb-irkTbqk908Ro-LX3_mN9nd_fVyPrvL2rwkY0ZaLqkSlShbqGhOCWtoIYzhpKkUMKh4IxkzEsAYI3IQjSo3AUtVKJDMsGP0feubAv2bdBzrvouttlY67adYlywnlNKcJZJsyTb4GIM29RC6XoZ1TaDeNFt_aDZpznbuU9Nr9abYVZmAn1ugc8aHXr74YFU9yrX1wQTp2i5uvD_3v3wnf9LSjk-tDLpe-Sm41Nx_vnsF9NKXSw</recordid><startdate>200911</startdate><enddate>200911</enddate><creator>Ohta, Yuko</creator><creator>Matsumura, Kiyoshi</creator><creator>Tsuchihashi, Takuya</creator><creator>Ohtsubo, Toshio</creator><creator>Arima, Hisatomi</creator><creator>Miwa, Yoshikazu</creator><creator>Goto, Kenichi</creator><creator>Ohya, Yusuke</creator><creator>Fujii, Koji</creator><creator>Uezono, Keiko</creator><creator>Abe, Isao</creator><creator>Iida, Mitsuo</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200911</creationdate><title>Improvement of Blood Pressure Control in a Hypertension Clinic in Japan: A 15-Year Follow-Up Study</title><author>Ohta, Yuko ; Matsumura, Kiyoshi ; Tsuchihashi, Takuya ; Ohtsubo, Toshio ; Arima, Hisatomi ; Miwa, Yoshikazu ; Goto, Kenichi ; Ohya, Yusuke ; Fujii, Koji ; Uezono, Keiko ; Abe, Isao ; Iida, Mitsuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-1c6a2d9897c0824213b259ff61b8d03086ba33fa00fff9409bd710647d5d0a3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adrenergic alpha-Antagonists - therapeutic use</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Aged</topic><topic>Angiotensin II Type 1 Receptor Blockers - therapeutic use</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>anti-hypertensive drugs</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Blood Pressure - drug effects</topic><topic>BP control</topic><topic>diuretics</topic><topic>Diuretics - therapeutic use</topic><topic>follow-up patients</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hypertension - blood</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Japan</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Outpatient Clinics, Hospital</topic><topic>Practice Guidelines as Topic</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>α-blockers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohta, Yuko</creatorcontrib><creatorcontrib>Matsumura, Kiyoshi</creatorcontrib><creatorcontrib>Tsuchihashi, Takuya</creatorcontrib><creatorcontrib>Ohtsubo, Toshio</creatorcontrib><creatorcontrib>Arima, Hisatomi</creatorcontrib><creatorcontrib>Miwa, Yoshikazu</creatorcontrib><creatorcontrib>Goto, Kenichi</creatorcontrib><creatorcontrib>Ohya, Yusuke</creatorcontrib><creatorcontrib>Fujii, Koji</creatorcontrib><creatorcontrib>Uezono, Keiko</creatorcontrib><creatorcontrib>Abe, Isao</creatorcontrib><creatorcontrib>Iida, Mitsuo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental hypertension (1993)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohta, Yuko</au><au>Matsumura, Kiyoshi</au><au>Tsuchihashi, Takuya</au><au>Ohtsubo, Toshio</au><au>Arima, Hisatomi</au><au>Miwa, Yoshikazu</au><au>Goto, Kenichi</au><au>Ohya, Yusuke</au><au>Fujii, Koji</au><au>Uezono, Keiko</au><au>Abe, Isao</au><au>Iida, Mitsuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improvement of Blood Pressure Control in a Hypertension Clinic in Japan: A 15-Year Follow-Up Study</atitle><jtitle>Clinical and experimental hypertension (1993)</jtitle><addtitle>Clin Exp Hypertens</addtitle><date>2009-11</date><risdate>2009</risdate><volume>31</volume><issue>7</issue><spage>553</spage><epage>559</epage><pages>553-559</pages><issn>1064-1963</issn><eissn>1525-6006</eissn><abstract>Many guidelines recommended strict blood pressure (BP) control to prevent cardiovascular events. However, BP control in a substantial majority of hypertensives remains to be insufficient. We have determined the trends of BP control of the same patients during 15 years in a hypertension clinic. One hundred three patients (age 32-91, mean 68 ± 11 years in 2006), who were followed at our hypertension clinic between 1991-2006, were retrospectively investigated. We compared the clinical characteristics of the patients in 2006 to those in 1991, 1996, and 2001, using the averaged BP determined at two occasions of each year for our analysis. The average BP decreased from 144 ± 17 87 ± 10 mmHg to 132 ± 12 75 ± 10 mmHg (p &lt; 0.01) during the 15 years between 1991 and 2006. When good BP control was defined as &lt; 140 90 mmHg, the rate of patients with good BP control increased from 35% in 1991 to 45% in 1996, to 54% in 2001 (p &lt; 0.01 vs. 1991), and to 72% in 2006 (p &lt; 0.01 vs. 1991). The number of anti-hypertensive drugs used in 2006 significantly increased compared to those in 1991, 1996, and 2001. More specifically, the use of diuretics and α-blockers increased significantly during this period. Results suggest that BP control improved in the 15 years studied, and the increased use of the anti-hypertensive drugs, as well as the increased awareness of the importance of strict BP control, seems to have contributed to improve the BP control.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>19886853</pmid><doi>10.3109/10641960902927960</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1064-1963
ispartof Clinical and experimental hypertension (1993), 2009-11, Vol.31 (7), p.553-559
issn 1064-1963
1525-6006
language eng
recordid cdi_proquest_miscellaneous_734122243
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Adrenergic alpha-Antagonists - therapeutic use
Adrenergic beta-Antagonists - therapeutic use
Aged
Angiotensin II Type 1 Receptor Blockers - therapeutic use
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
anti-hypertensive drugs
Antihypertensive Agents - therapeutic use
Blood Pressure - drug effects
BP control
diuretics
Diuretics - therapeutic use
follow-up patients
Follow-Up Studies
Humans
Hypertension - blood
Hypertension - drug therapy
Hypertension - physiopathology
Japan
Male
Middle Aged
Outpatient Clinics, Hospital
Practice Guidelines as Topic
Renin-Angiotensin System - drug effects
Retrospective Studies
Time Factors
Treatment Outcome
α-blockers
title Improvement of Blood Pressure Control in a Hypertension Clinic in Japan: A 15-Year Follow-Up Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T16%3A45%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improvement%20of%20Blood%20Pressure%20Control%20in%20a%20Hypertension%20Clinic%20in%20Japan:%20A%2015-Year%20Follow-Up%20Study&rft.jtitle=Clinical%20and%20experimental%20hypertension%20(1993)&rft.au=Ohta,%20Yuko&rft.date=2009-11&rft.volume=31&rft.issue=7&rft.spage=553&rft.epage=559&rft.pages=553-559&rft.issn=1064-1963&rft.eissn=1525-6006&rft_id=info:doi/10.3109/10641960902927960&rft_dat=%3Cproquest_cross%3E734122243%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-1c6a2d9897c0824213b259ff61b8d03086ba33fa00fff9409bd710647d5d0a3f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734122243&rft_id=info:pmid/19886853&rfr_iscdi=true